KPV Tablets
(Oral Delivery of α-MSH Fragment Peptide)
KPV (Lys-Pro-Val) is a short peptide fragment derived from alpha-melanocyte-stimulating hormone (α-MSH), widely studied for its role in immune regulation, inflammation control, and epithelial barrier integrity. In oral tablet form, it offers a convenient delivery method for research involving systemic and gut-related inflammatory responses. Areas of current research include:
-
Gut Health and Inflammation
KPV is being investigated for its potential to support intestinal barrier function and reduce pro-inflammatory cytokines in the GI tract. -
Systemic Immune Modulation
Researchers are exploring its role in suppressing inflammatory pathways, particularly those involving TNF-α, IL-1β, and NF-κB. -
Skin, Mucosal, and Autoimmune Models
KPV is being studied for its effects in models of dermatitis, colitis, and other epithelial inflammatory conditions.
How It Works
KPV functions through non-stimulatory melanocortin receptor pathways, particularly MC1R, where it is believed to exert anti-inflammatory effects without affecting melanogenesis or endocrine activity. It may help suppress NF-κB activation and reduce cytokine-driven inflammation. In tablet form, KPV offers a promising route for research involving localized gut inflammation, systemic immune balance, and chronic inflammatory conditions, all while bypassing injectable administration.
⚠️ Important Notice:
This product is sold strictly for laboratory research purposes only. It is not for human or animal use, and not for therapeutic or diagnostic applications.
By purchasing, you confirm that you are a qualified individual using this product in accordance with all applicable laws and research regulations.
